A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM) - Archive ouverte HAL Access content directly
Journal Articles American Journal of Respiratory and Critical Care Medicine Year : 2017

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)

, (1) , , , , , , , (2) , (3, 4) , (5) , , , , , , (6) , , , , , , , , , (7) ,
1
2
3
4
5
6
7
Samuel Kemp
  • Function : Author
Alan Kirk
  • Function : Author
Malgorzata Kornaszewska
  • Function : Author
Kris Carron
  • Function : Author
Lars Ek
  • Function : Author
Gustav Broman
  • Function : Author
Gunnar Hillerdal
  • Function : Author
Nicola Downer
  • Function : Author
Kaid Darwiche
  • Function : Author
Jagan Rao
  • Function : Author
Ralf-Harto Hübner
  • Function : Author
Christof Ruwwe-Glosenkamp
  • Function : Author
Ralf Eberhardt
  • Function : Author
Felix Herth
  • Function : Author
Eric Derom
  • Function : Author
Thomas Mal
  • Function : Author
Pallav Shah
Justin Garner
  • Function : Author
Nick ten Hacken
  • Function : Author
Hazem Fallouh
  • Function : Author
Charles Marquette
  • Function : Author

Abstract

Single-center randomized controlled trials of the Zephyr endobronchial valve (EBV) treatment have demonstrated benefit in severe heterogeneous emphysema. This is the first multicenter study evaluating this treatment approach.

Dates and versions

hal-01963139 , version 1 (21-12-2018)

Identifiers

Cite

Samuel Kemp, Dirk-Jan Slebos, Alan Kirk, Malgorzata Kornaszewska, Kris Carron, et al.. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM). American Journal of Respiratory and Critical Care Medicine, 2017, 196 (12), pp.1535-1543. ⟨10.1164/rccm.201707-1327OC⟩. ⟨hal-01963139⟩
64 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More